Recursion Pharmaceuticals Stock Tumbles to 52Week Low Amid Market Pressures
US GDP Growth Revised Lower for First Quarter Economic Expansion Slows
Three Signs from APEC That US and China Remain Far Apart on Trade
Treasury Yield Surge Prompts Bond Investors to Seek Alternative FixedIncome Opportunities
Uncertainty and Caution in Tech Employment Data CompTIA Analysis Reveals
GLP1 Weight Loss Drugs Driving Up Prescription Costs CoPays Expected to Rise
DERM Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Shares Decline
BFLY Q1 2026 Earnings EPS Beat Surprises as Butterfly Network Posts Narrower Loss
Voyager Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response
JBHT Q1 2026 Earnings EPS Beats Estimates as Operational Efficiency Drives Performance
Teck Resources Q1 2026 Earnings EPS Beats Estimates by Over 53 Despite Modest Market Pullback
GM Q1 2026 Earnings Blowout EPS Surprise Drives Shares Higher
Pacific Biosciences PACB Edges Higher But Key Resistance Remains a Hurdle
GSUN Rebounds From Support Golden Sun Technology Group Gains 325
Corvus Pharmaceuticals CRVS Rallies 174 Technical Breakout or Consolidation
Amphastar Pharmaceuticals AMPH Gains 138 as Stock Consolidates Near Key Resistance
Mount Logan Capital Notes MLCIL Hold Steady at 2295 No Momentum as Key Levels Firm
Chinas Push for Humanoid Robot Workforce Raises Competitive Stakes
INVX Q1 2026 Earnings EPS Surges 1015 Above Estimates Revenue Not Disclosed Stock Declines 25
Sypris Solutions SYPR Surges Over 6 Testing Key Resistance at 348